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Chronic Adolescent Cannabis Exposure Leads to Schizophrenia-Related Phenotypes Through
Pathological Alterations of the Hippocampal Formation
1. Abstract
Chronic adolescent exposure to D9-tetrahydrocannabinol (THC), the psychoactive component in
marijuana, induces a schizophrenia-resembling phenotype in adulthood. Substantial evidence has
suggested that schizophrenia is associated with a dysregulation of distinct brain regions, among
which one of them is that of the hippocampal formation. In the present study, we used an integrative
combination of behavioural assays and molecular analyses in a neurodevelopmental rodent model
to demonstrate that hippocampal dysfunction, and a functional dissociation between the dorsal and
ventral subregions, contributes to the emergence of psychotic-like symptoms of adolescent THCinduced schizophrenia. We report that adolescent exposure to THC induces cognitive and affective
disturbances characterized by impairments in spatial memory formation, onset of anxiety-like
behaviours and alterations in receptor and neurotransmitter levels. These results implicate
dysfunction in hippocampal signalling as a critical nexus point mediating THC-induced schizophrenic
phenotypes. We anticipate that our results will pave the way for finding new neurochemical targets
that therapeutical interventions can potentially alter to revert the impairments.

Keywords: Schizophrenia; Adolescence; D9-tetrahydrocannabinol; Dorsal hippocampus; Ventral
hippocampus

Word count: 5199

2.

Introduction
Schizophrenia is a severe neuropsychiatric disease characterized by three categories of

symptoms: positive symptoms (delusions, hallucinations, disorganized speech), negative symptoms
(alogia, anhedonia, social withdrawal), and cognitive deficits (American Psychiatric Association,
2013). Schizophrenia has a multifactorial etiology, with both genetic determinants and
environmental contributors, such as substance abuse, increasing susceptibility to the disease.
Marijuana is the most commonly used illicit drug for recreational purposes (Radhakrishnan et al.,
2014). This has especially critical implications for adolescents between 12–17 years of age given that
their brains are especially pliable and susceptible to extrinsic insult. In fact, this period incurs
extensive remodelling of various neurotransmitter pathways, such as the endocannabinoid,
mesocorticolimbic, and glutamatergic systems, whose reorganization is susceptible to insult by
extrinsic stressors. Converging lines of evidence suggest that sustained and heavy exposure to
cannabis during this critical neurodevelopmental period increases the risk of neuropsychiatric
diseases in adulthood (Andreasson et al., 1987; Kuepper et al., 2011).
The endocannabinoid (eCB) system is a neuromodulator of the central nervous system
and is critical for adolescent neurodevelopment, maintenance of synaptic plasticity, neuronal
migration, and response to intrinsic and extrinsic agents. The eCB system is comprised primarily of
CB1 (CB1R) and CB2 cannabinoid receptors and the endogenous cannabinoids that engage them (Lu
and Mackie, 2016). In humans, CB1R expression increases throughout adolescence, with the most
robust increases occurring in the prefrontal and hippocampal regions (Mato et al., 2003). D9tetrahydrocannabinol (THC), the psychoactive component in marijuana, is an efficacious CB1
receptor partial agonist (Herkenham et al. 1990). Given the importance of the eCB system in
adolescent neurodevelopment, it is likely that environmental modulation of eCB signalling during
this susceptible period can cause long-lasting neurobiological changes that would ultimately impair
the functioning of the mature adult brain. For instance, persistent exposure to THC could induce

sustained activation of CB1Rs in the prefrontal and hippocampal regions, which would modulate
dopaminergic transmission in the mesocorticolimbic system, and ultimately result in
neurodevelopmental impairments resembling schizophrenia.
Substantial evidence has implicated aberrant activity of the mesocorticolimbic dopamine
pathway during adolescent neurodevelopment as a crucial contributor to the onset of schizophrenia.
This pathway consists of two distinct sets of dopaminergic neurons projecting from the ventral
tegmental area (VTA): the mesolimbic pathway which projects to the nucleus accumbens (NAc) of
the ventral striatum, and the mesocortical pathway which projects to the prefrontal cortex (PFC).
According to the dopamine hypothesis, excessive dopaminergic output to the striatum, along with
dopaminergic deficits in the frontal cortices, herald the emergence of the associated
psychopathological symptoms (Howes and Kapur, 2009). However, dopaminergic neurons
projecting from the midbrain of the VTA have been shown to form a functional loop with the
hippocampus, which prompted researchers to propose that dopaminergic dysfunction in
schizophrenia may actually be secondary to the disruption of upstream hippocampal regulation. The
hippocampal formation is a temporal lobe structure essential for memory consolidation and is both
structurally and functionally heterogeneous. Its anterior and posterior portions, corresponding
respectively to the ventral (vHipp) and dorsal (dHipp) hippocampus in rodents, are responsible for
different cognitive functions as they have different afferent and efferent neural networks (Benetti et
al., 2009). With respect to the connectivity between the prefrontal and hippocampal regions, the
hippocampus receives indirect projections from the ipsilateral medial prefrontal cortex (Roberts et
al., 2006). Previous studies analyzing cognitive models of schizophrenia have observed perturbed
connectivity between the prefrontal cortex and anterior and posterior hippocampal regions in first
episode schizophrenic patients (Benetti et al., 2009). Moreover, Ragland et al. (2016) demonstrated
that the posterior hippocampus is hypoactive and the anterior hippocampus is hyperactive in
patients with schizophrenia. Additionally, the size of the posterior hippocampal pyramidal neurons

has been found to be reduced in schizophrenic subjects (Benes et al., 1991). Thus, substantial
evidence has evidently suggested that schizophrenia is associated with a dysregulation of distinct
brain regions, among which one of them is that of the hippocampal formation.
Animal models are valuable tools for examining the long-term molecular, neuronal and
behavioural effects of sustained cannabis exposure during adolescence. The laboratory of Dr. XXX
(supervisor name has been redacted for anonymity) has previously demonstrated in a
neurodevelopmental rodent model that chronic adolescent exposure to THC induces a
schizophrenia-resembling behavioural phenotype characterized by long-lasting cognitive
impairments. Moreover, the neuropathological alterations include a THC-induced hyperactivity of
the PFC pyramidal neurons, accompanied by hyperactive DAergic neuronal activity in the VTA,
concomitant with a loss of GABAergic inhibitory control within the PFC (this citation has been
redacted for anonymity).
Additional relevant findings, previously established in Dr. XXX’s (supervisor name has
been redacted for anonymity) laboratory, demonstrated that cannabinoid modulation, directly in
the hippocampus, elicited neuropsychiatric symptoms resembling a schizophrenia phenotype. X et
al. (2019) demonstrated that direct bilateral intra-vHipp local injections of THC induced anxiety-like
behaviour, in otherwise healthy rats, using the light/dark box anxiety test, based on a rat’s natural
aversion to bright environments. Specifically, drug-treated rats exhibited a significantly longer
latency to emerge into the light compartment relative to their VEH-control counterparts. The latency
time to re-enter from the dark to the light environment is considered to be the most important
parameter to test anxiety. Moreover, X et al. (2015) demonstrated that local injection of WIN55, a
synthetic CB1R agonist, directly into the vHipp was able to induce hyperactivation of the VTAdopamine system in rodents. These findings implicate the hippocampus as a brain region that
cannabinoids can manipulate to produce the associated neuropsychiatric phenotypes of
schizophrenia. Moreover, a previous study states that the dHipp forms connections with the frontal

cortical structures and is responsible for cognitive processes such as memory recall and spatial
learning. Conversely, the vHipp is responsible for emotional processing, such as anxiety (Fanselow
and Dong, 2010). The vHipp regulates dopaminergic (DAergic) activity via a polysynaptic projection:
vHipp glutamatergic inputs excite neurons in the NAc that, in turn, release γ-aminobutyric acid
(GABA) at the ventral pallidum (VP), inhibiting its activity. The VP provides an inhibitory tone to the
dopaminergic neurons of the VTA, therefore activation of the vHipp will increase dopaminergic
activity at the VTA. Several lines of evidence have suggested hippocampal dysregulation as a
contributor to schizophrenia-related DA dysfunction (Lodge and Grace, 2011).
Therefore, in this present study, our goal was to combine the established findings that (i)
marijuana abuse during adolescence increases the risk of schizophrenia and, (ii) hippocampal
dysfunction contributes to the disease burden. Using a validated rodent model, we hypothesized that
long-term alteration of the brain’s hippocampal formation, and functional dissociation between
dHipp and vHipp, underlie the pathological dysregulation of the mesocorticolimbic system, leading
to the psychotic-like symptoms of THC-induced schizophrenia.

3. Materials and methods
3.1.

Subjects

Adolescent male Sprague-Dawley rats from Charles River Laboratories (Quebec, Canada) were
obtained at postnatal day (PND) 28. Upon arrival, rats were housed in pairs under controlled
conditions (12:12 light/dark cycle, constant temperature and humidity) and received food and water
ad libitum. The total number of animals used for this study was 64: 16 vehicle and 16 THC rats were
used for behavioral tests, 7 vehicles and 9 THC rats for protein analysis as well as 8 vehicles and 8
THC rats for MALDI studies. All experimental procedures were conducted in accordance with
Governmental and Institutional guidelines for appropriate laboratory animal care and
experimentation.

3.2.

Drug Preparation and Administration

Male Sprague-Dawley rats received a dosing regimen of THC (Tocris, UK) or vehicle (VEH)
intraperitoneal injections twice daily between postnatal days (PND) 35–45, a window comparable
with adolescence in humans. The drug solution was prepared by dissolving THC in an ethanol,
cremophor and saline (1:1:18) solution. Ethanol was subsequently evaporated using nitrogen gas.
Dosages were administered at increasing concentrations (2.5 mg/kg; Days 1–3; 5 mg/kg; Days 4–7;
10 mg/kg, Days 8–11) to counteract drug tolerance development, by desensitization of the CB1
receptors, and to mimic a heavy smoking regimen. The volumes were adjusted per body weight. This
protocol has been performed as previously described (Renard et al., 2016; 2017). Behavioural tests
were initiated following a 30-day drug-free period at PND 75, a window comparable with adulthood
in humans.

3.3.

Behavioural experiments

Light-Dark Box Anxiety Test
The light-dark box behaviour task took place in a test apparatus consisting of two 50 × 25 × 37 cm
compartments connected by a 10 × 10 cm opening. The ‘dark box’ was black and enclosed by a black
lid, while the ‘light box’ was white, left uncovered, and illuminated by a lamp, providing 1500 lux,
located 120 cm above the apparatus floor. The door allowed the rat to enter either compartment. The
experiment commenced when a rat was placed at the center of the light box, facing the wall opposite
the door, and allowed to explore both compartments freely for a subsequent 8 minutes. A rat’s entry
into a zone was considered to have occurred when it placed all 4 paws in that zones compartment.
Experiments were recorded and subsequently analyzed offline with a video-tracking system
(BehaView). The behaviors analyzed included: i) latency time to first enter the dark box; ii) latency
time to re-enter the light box, and iii) total number of transitions between compartments (Renard et
al., 2016).

Elevated Plus Maze Anxiety Test
The elevated plus maze (EPM) apparatus consists of 4 arms (10 x 50 cm) branching from a platform
(10 x 10 cm) to form a plus shape. It was mounted 50 cm above the floor and dimly illuminated (40
lux). Two opposing arms were enclosed by 40 cm high walls (closed arms) while the other two arms
were open with the exception of a 1cm high ledge (open arms). The experiment commenced when a
rat was placed on the central platform, facing the closed arm, and allowed to explore the maze freely
for a subsequent 10 minutes. A rat’s entry into a respective arm was considered to have occurred
when it placed all 4 paws in that arm. Experiments were recorded and subsequently analyzed offline
with a video-tracking system (BehaView). The behaviors analyzed included: i) number of entries and
ii) time spent in either the closed or open arms (Szkudlarek et al., 2019).

Object Location Memory Task
The object location apparatus consisted of an 80 x 80 cm black acrylic arena enclosed by 50 cm high
walls with a distinctive orientation cue on one wall. The task included three phases: i) habituation,
ii) training and iii) test. During the habituation phase, rats were individually allowed to explore the
arena devoid of objects for 20 minutes to acclimate themselves to the environment. 24 hours later,
during the training phase, the rats were re-introduced to the same arena, in the presence of a pair of
identical objects, made of either glass or plastic of similar dimensions, placed 15 cm away from either
corner of the arena. The experiment commenced when a rat was placed at the center of the arena,
facing the objects, and allowed to explore them freely for a subsequent 3 minutes. 1 hour later, during
the 1st condition of the test phase, rats were re-introduced to the same context for 3 minutes, with
the same objects, but with the exception of one of the object’s position being changed to another
corner of the arena. The delay of 1 hour was chosen to investigate short-term memory for object
location recognition. The following day, during the training phase, the rats were introduced to the
same context for 3 minutes, with a pair of identical objects, but different of those used on the previous

day. 5 hours later, during the 2nd condition of the test phase, rats were tested for 3 minutes in the
same context and with the same objects, with the exception of one of the object’s position being
changed to another corner of the arena. The delay of 5 hours was chosen to investigate long-term
memory for object location recognition. After each test, the apparatus and objects were wiped down
with 70% ethanol solution to avoid olfactory cue bias. The training and test phases were recorded
and subsequently analyzed offline using a video-tracking system (BehaView). Object position was
counterbalanced between rats. The recognition of a change in object location was defined by whether
the subject spent more time exploring the object in the novel location. Exploration was defined when
rats were sniffing an object. The preference for a novel object was conveyed using an object location
recognition index (the time spent with a novel object/total time exploring both objects) expressed as
a percentage.

3.4.

Protein Extraction and Western Blotting

Rats were overdosed with intraperitoneal injections of sodium pentobarbital (240 mg/kg, i.p.,
EuthanylTM) and decapitated. Brains were removed and flash frozen. Bilateral micropunches of the
ventral and dorsal hippocampus were isolated for protein isolation. A standard Western blotting
procedure was performed as previously described (Lyons et al., 2013). Antibody dilutions were as
follows: α-tubulin (mouse, 1: 7500; Sigma; rabbit, 1:5000; Santa Cruz Biotechnology),
phosphorylated mTOR ser2448 (p-mTOR; rabbit, 1:1000; Cell Signaling Technology), total mTOR (tmTOR; rabbit, 1:1000; Cell Signaling Technology), NMDAR2B (NR2B; rabbit, 1:750; Cell Signaling
Technology), mGluR2/3 (rabbit, 1:750; Millipore), GAD67 (mouse, 1:5000; Millipore). Speciesappropriate secondary antibodies used for detection were fluorophore-conjugated (LI-COR
IRDye680RD and IRDye 800CW) (1:10000; Thermo Scientific). Membranes were scanned using a LICOR Odyssey Infrared Imaging System and densitometry measurement were obtain using Image
Studio Lite software and normalized to the signal intensity obtained for the α-tubulin.

3.5.

Matrix-Assisted Laser Desorption/Ionization Imaging Mass Spectrometry (MALDIIMS)

Rats were overdosed with intraperitoneal injections of sodium pentobarbital (240 mg/kg, i.p.,
EuthanylTM) and brains were removed and flash frozen. Brains from VEH and THC-treated rats were
randomly paired, sectioned to a thickness of 10 μm at -20°C using a cryostat (CM 1850, Leica
Biosystems, Wetzlar, Germany) to collect ventral and dorsal hippocampus (-6 from bregma), and
mounted onto the indium-tin-oxide (ITO) coated glass slides (Hudson Surface Technology, Old
Tappan, NJ). Prior to matrix deposition, slides were dried in a desiccator under vacuum for half an
hour. ZnO NP dispersion (Sigma-Aldrich, St. Louis, MO) was sprayed onto tissue sections using a TMSprayer (HTX Technologies, Chapel Hill, NC) at the following conditions: 1.0 mg/mL of ZnO NP
dispersion in ACN/H2O (50/50%, vol), flow rate of 0.05 mL/min, nozzle temperature at 65 °C,
moving nozzle velocity of 1200 mm/min, 32 passes, 3 mm line spacing and pressure of 10 psi. A Sciex
5800 MALDI TOF/TOF mass spectrometer (Framingham, MA) equipped with a 349 nm Nd: YLF laser
with a pulse rate at 400 Hz was used and images was acquired with Sciex TOF-TOF Series Explorer
and TOF-TOF Imaging. For MS mass calibration, 0.75 µL of 5.5 mg/mL α-cyano-4-hydroxycinnamic
acid (CHCA, Sigma-Aldrich, St. Louis, MO) solution containing ACN/H2O/TFA (50/50/0.1%, v/v/v)
was spotted, and the calibration was based on the following ions with m/z: [CHCA-H2O+H]+ at
170.04 Da, [CHCA+H]+ at 190.05 Da, [CHCA+Na]+ at 212.03 Da, [CHCA-H+2Na]+ at 234.01 Da and
[2CHCA+H]+ at 379.09 Da. Mass spectra were acquired from m/z range of 50 to 500 Da in the positive
mode and the spatial resolution for IMS was at 80 µm. For each pixel, the mass spectra were acquired
by averaging signals from 40 to 60 shots. The laser intensity for IMS was optimized based on the
number of signals from m/z range of 50 to 500 Da, peak resolution, and signal to noise ratio.
MSiReader (developed by North Carolina State University) was used to display ion distributions
within the tissue sections and to export the data from regions of interest for quantitation. For relative
quantitation, the areas of the peaks corresponding to [GABA+K]+ at m/z 142 and [glutamic acid+K]+

at m/z 186 were integrated, and the peak area ratios between THC and VEH were obtained for
subsequent statistical analysis (this citation has been redacted for anonymity).

Statistical analysis
Statistical analyses were performed using SPSS Statistics version 24 (IBM). Sampled data were tested
for statistical comparisons between groups using unpaired or one-sample Student’s t test. The
significance level was established at P < 0.05.

4. Results
4.1.

Behavioural Tests

Adolescent THC Exposure Induces Anxiety-Like Behaviour
We investigated the effects of adolescent THC exposure on anxiety-like behaviours using the lightdark box test. The light-dark box is based on the natural aversion of rats to bright environments. The
latency time to re-enter the light box is thought to be the most important parameter to test anxietylike behaviour. As such, statistical analysis revealed that THC-treated rats exhibited a significantly
longer latency to emerge into the light compartment relative to their VEH-control counterparts (t30=
-2.12, P < 0.05; Fig. 1B). To further examine the potential effects of adolescent THC exposure on
anxiety-like behaviors, we used the elevated plus maze test. An increase in open arm duration and/or
entries is reflective of anti-anxiety behavior. There was no significant effect of THC treatment on time
spent in the open arms (t27 = 0.845, P > 0.05; Fig. 1D) or on the number of open arm entries (t27 =
1.248, P > 0.05; Fig. 1E) relative to the VEH-treated control rats.

Adolescent THC Exposures Induces Deficits in Long-Term Memory Measures
We next compared the effects of adolescent THC exposure on short-term or long-term spatial
memory deficits for object location recognition using the object-location memory task. Statistical
analysis revealed no significant differences in time spent exploring the novel location/object bias
following 1 hour delay (t30= 1.18, P > 0.05; Fig. 1G). However, adolescent THC treatment impaired the
formation of object location recognition relative to vehicle controls in the 5h retention test (t30 = 2.33,
P < 0.05; Fig. 1H).

4.2.

Dorsal Hippocampus Western Blot Analysis

Adolescent THC Exposure Induces Significant Decreases in GAD67 and NR2B Protein Levels
We next analyzed protein expression levels of selected molecular signaling pathways relevant for
both schizophrenia and THC exposure. Western blot analysis of protein expression levels of GAD67,
the primary GABA-synthesizing enzyme in the dorsal hippocampus, revealed a decrease in
adolescent THC versus VEH-treated rats (t12 = 2.01, P < 0.05; Fig. 2A). Moreover, a significant decrease
was detected in protein levels of NMDAR2B (NR2B) (t13 = -2.17, P < 0.05; Fig. 2B) between groups,
while no significant difference was detected in levels of mGluR2/3 (t11 = 0.709, P > 0.05; Fig. 2C).
Analysis of p-mTOR revealed a trend of significance induced by THC treatment (t12 = 1.75, P = 0.05;
Fig. 2D). However, THC exposure did not affect the expression of t-mTOR protein levels (t12 = 0.67, P
> 0.05; Fig. 2D) or the ratio of p-mTOR/t-mTOR (t12 = 1.40, P > 0.05; Fig. 2D).

4.3.

Ventral Hippocampus Western Blot Analysis

Adolescent THC Exposure Induces Significant Increases in mGluR2/3 and NR2B Protein Levels
In contrast to the results observed in the dorsal hippocampus, western blot analysis of ventral
hippocampal protein expression revealed a significant increase in NMDAR2B (NR2B) (t13 = -2.17, P <
0.05; Fig. 3B) and mGluR2/3(t14 = -2.16, P < 0.05; Fig. 3C) induced by adolescent THC exposure, while

no differences were detected in protein expression levels of GAD67 (t10 = -0.84, P > 0.05; Fig. 3A)
between groups. Moreover, THC treatment did not affect the levels of p-mTOR (t10 = -0.81, P > 0.05;
Fig. 3D), the expression of t-mTOR (t10 = -1.15; P > 0.05; Fig 3D) as well as the ratio of p-mTOR/tmTOR (t10 = -0.14, P > 0.05; Fig. 3D) when compared with VEH-treated rats.

4.4.

Dorsal and Ventral Hippocampus MALDI Analysis of GABA and Glutamate

Adolescent THC Exposure Induces Significant Decreases in GABA Neurotransmitter Levels
MALDI mass spectrometric analysis successfully obtained quantitative information on the relative
abundance and spatial distribution of [GABA+K] and [glutamic acid+K] within the dorsal and ventral
hippocampus between THC and VEH treated rats. Statistical analysis revealed a significant decrease
in the peak area ratios (THC/VEH) of GABA (t7 = -9.95, P < 0.001; Fig. 4B), and a trend of significance
in glutamate (t7 = -1.89, P = 0.05; Fig. 4B), in the dorsal hippocampus. Accordingly, statistical analysis
detected a significant decrease in the peak area ratios (THC/VEH) of GABA (t7 = -2.13, P < 0.05;
Fig.4C), and no significant difference in glutamate (t7 = -1.18, P > 0.05; Fig. 4C), in the ventral
hippocampus.

5. Discussion
Numerous studies have implicated adolescent cannabis consumption as a risk factor for
developing schizophrenia later in life (André asson et al., 1987). Moreover, substantial evidence has
shown that aberrant activity during adolescent neurodevelopment of the endocannabinoid and
mesocorticolimbic system, and specifically the cortical-hippocampal pathway, is a crucial contributor
to the onset of schizophrenia in adulthood (Lu and Mackie, 2016; Ragland et al., 2016; Howes and
Kapur, 2009; Benetti et al., 2009; Benes et al., 1991). Given these previously established findings, here
we demonstrate that long-term alteration of the brain’s hippocampal formation, through chronic
exposure to THC during a window comparable to adolescence, can induce molecular and behavioural

phenotypes resembling schizophrenia. Our present findings reveal that adolescent exposure to THC
induces cognitive and affective disturbances characterized by impairments in spatial memory
formation, onset of anxiety-like behaviours and alterations in receptor and neurotransmitter levels.
Using light-dark box behavioural testing, we found that rats exposed to THC during
adolescence displayed a significant increase in anxiety-like behaviour at adulthood, consistent with
our previous reports (X et al. 2016; 2017). This finding is corroborated by the fact that adolescent
THC-treated rats demonstrated a longer latency to re-emerge into the light compartment following
entrance into the dark environment, indicative of anxiety. Anxiety-related symptoms are a
phenomenon commonly reported in schizophrenia. However, we observed no significant difference
in anxiety levels between THC and VEH treated rats during elevated plus maze (EPM) paradigms.
Several possible reasons may account for this statistical insignificance. For instance, the data
obtained from anxiety assays, such as the EPM test, are typically less consistent and can be impacted
by external factors and/or the genetic background of experimental animals (Renard et al., 2006). In
addition to anxiety measures, we observed that rats receiving adolescent THC exposure displayed
deficits in recognizing a change in object location, indicative of disturbances in spatial memory
consolidation. The recognition of a change in object location was defined by whether the subject
spent more time exploring the object in the novel location. Significant deficits in location recognition
memory, demonstrated by their inability to discriminate between the familiarity of recently
encountered object locations to the foreignness of novel object locations, were observed in the 5h
retention test but not in the 1h. These findings suggest that sustained adolescent THC exposure leads
to impairments in long-term spatial memory formation as opposed to short-term. Memory-related
impairments represents another core cognitive feature of schizophrenia (Elvevag and Goldberg,
2000). Specifically, impairments in spatial memory is among one of the modalities that a
schizophrenic patient demonstrates working memory deficits for (Park and Holzman, 1992).
Consequently, the delayed-response task of object location recognition was chosen for this study as

it is a measure of spatial memory and it is predominantly associated with the hippocampus. In fact,
the hippocampus is mainly implicated in regulating spatial memory and anxiety responses (Moser et
al., 1995; Henke, 1990), with the dorsal and ventral portions taking on different roles. The dHipp is
responsible for cognitive processes such as memory recall and spatial learning, whereas the vHipp is
responsible for emotional processes, such as anxiety (Fanselow and Dong, 2010).
Upon characterizing the behavioural phenotypes of adolescent THC-induced hippocampal
dysfunction, we sought out to identify the molecular underpinnings of the resulting schizophrenic
psychopathology. We performed a series of molecular analyses within the dorsal and ventral
hippocampus. Using western blotting, we observed that adolescent THC exposure induces significant
decreases in GAD67 and NR2B protein levels in the dHipp, and significant increases in mGluR2/3 and
NR2B protein levels in the vHipp. The NMDA receptor 2B subunit (NR2B) is a member of the
ionotropic glutamate receptor family (Cohen et al., 2015). We report here for the first time that
adolescent THC exposure induces an imbalance in glutamate transmission through an opposing
increase/decrease of NR2B expression levels among hippocampal subregions. This could potentially
reflect a compensatory effect of one subregion to counteract the other in order to maintain the
balance in the system. Our finding is supported by a previous study that used fMRI testing to analyze
the impact of schizophrenia on the anterior and posterior hippocampus during spatial memory
retrieval. Ragland et al. (2016) observed a reduced posterior and an increased anterior hippocampal
activation during recognition of spatial changes. While Ragland et al. (2016) obtained these results
on the behavioural level at the clinical stage, our study was able to observe a similar dissociation on
the molecular level at the pre-clinical stage, thus confirming that this imbalance is a consistent finding
among publications. Moreover, the hippocampal hyperactivity observed in human schizophrenia
patients corresponds with other studies that have found a hyperactivity in the ventral hippocampus
of schizophrenia rodent models as well (Lodge and Grace, 2011).

Furthermore, in order to investigate whether this imbalance is confirmed or related to
neurotransmitter quantification, we analyzed the relative abundance and spatial distribution of
[GABA+K] and [glutamic acid+K], two cardinal neurotransmitters that are altered in schizophrenia,
using MALDI-IMS mass spectrometry. To our knowledge, this is the first study using MALDI to report
that adolescent THC exposure induces significant decreases in GABA neurotransmitter levels in both
the ventral and dorsal hippocampus. This was an unexpected finding considering that, during
detection of GABA decreases, receptor expression levels in the ventral hippocampus were
concertedly increasing. Although this finding was not anticipated, it can be accounted for by the fact
that receptor expression levels do not always coincide with the neurotransmitter distribution
detected by MALDI in that area. It is known that receptors can be desensitized by means of
internalization and downregulation in response to sustained and chronic exposure to agonists. For
instance, Renard et al. (2016) previously demonstrated that adolescent THC exposure induces a
hyperactivity of the PFC pyramidal neurons, which are known to form connections with the dHipp
neuronal populations. The subsequent influx of glutamate in the dHipp might overwhelm the NR2B
receptors of that area, causing them to desensitize and decrease in expression levels to protect
against overstimulation. To compensate, the vHipp would increase its respective NR2B receptor
levels to restore homeostasis. Thus, one could speculate that GABA neurotransmitter levels
decreasing in both subregions may reflect the fact that it did not necessitate any form of balancerestoring adaptations.
A number of limitations in our experimental approach may have restricted the outcomes of
this study. Among the conventional imaging techniques and mass spectrometry-based platforms,
MALDI is a relatively novel profiling strategy. Though it offers the unique advantage of directly
visualizing the distribution of neurotransmitters from a tissue specimen, it lacks a database of
publications from which we could compare, validate and rationalize our data to. Owing to this limited
data availability, future studies are required to more fully investigate its implications. For instance,

MALDI can be used in tandem with alternative neuroimaging approaches, such as proton magnetic
resonance spectroscopy (H-MRS), positron emission tomography (PET) and single photon emission
computed tomography (SPECT) (Egerton et al., 2017). Another limitation is the use of animal models
as a framework for studying neuropsychiatric diseases. It is impossible to fully reproduce
schizophrenia in its entirety due to the nature and complexity of human symptoms (Viveros et al.,
2011).
In summary, the present findings demonstrate that hippocampal dysfunction, and a
functional dissociation between the dHipp and vHipp, contribute to the emergence of psychotic-like
symptoms of adolescent THC-induced schizophrenia. Though future studies are required to more
fully characterize the mechanisms underlying the alteration, our study may pave the way for finding
new neurochemical targets that therapeutical strategies and interventions can potentially alter to
revert the impairments. Given that adolescence represents a vulnerable neurodevelopmental period,
and the exponential rise in cannabis use among youth, these findings have critical implications for
public health.
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Figure 1. Effects of adolescent THC exposure on measures of anxiety and memory. (A) Schematic apparatus of the light-dark task.
Group sizes (n): VEH (16), THC (16). (B) THC exposure during adolescence induced anxiety-like behaviours as increased latency to emerge
into the light compartment compared to their VEH-control counterparts. (C) Schematic summary of the elevated plus maze task. Group
sizes (n): VEH (14), THC (15). Anxiety-like behaviours were not observed as there was no significant effect of THC treatment on time spent
in the open arms (D) or on the number of open arm entries (E) relative to the VEH-treated control rats. (F) Schematic summary of the
object location task. Group sizes (n): VEH (16), THC (16). THC exposure during adolescence did not induce short-term (G) but did induce
long-term (H) spatial memory deficits in the object location recognition task. Respective treatment groups were compared using unpaired
Student’s t test. * indicated p < 0.05. Error bars represent the standard error of the means (SEMs).
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Figure 2. Effects of adolescent THC exposure on dorsal hippocampal protein biomarkers. (A) Representative western blot for GAD67
expression in the dHipp (top). A significant decrease in GAD67 expression is observed between adolescent THC (n=7) versus VEH-treated
(n=7) rats. (B) Representative western blot for NR2B expression in the dHipp (top). A significant decrease in NR2B expression is observed
between adolescent THC (n=8) versus VEH-treated (n=7) rats. (C) Representative western blot for mGluR2/3 expression in the dHipp
(top). No significant changes in mGluR2/3 were found between groups. Group sizes (n): VEH (6), THC (7). (D) Representative western

blot for p-mTOR and t-mTOR expression in the dHipp (top). No significant changes in p-mTOR, t-mTOR and the ratio of phosphorylated to
total mTOR were found between groups. Group sizes (n): VEH (7), THC (7). Respective treatment groups were compared using unpaired
Student’s t test. * indicated p < 0.05. Error bars represent the standard error of the means (SEMs).
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Figure 3. Effects of adolescent THC exposure on ventral hippocampal protein biomarkers. (A) Representative western blot for
GAD67 expression in the vHipp (top). No significant changes in GAD67 were found between groups. Group sizes (n): VEH (6), THC (6). (B)
Representative western blot for NR2B expression in the vHipp (top). A significant increase in NR2B expression is observed between
adolescent THC (n=8) versus VEH-treated (n=7) rats. (C) Representative western blot for mGluR2/3 expression in the vHipp (top). No
significant changes in mGluR2/3 were found between groups. Group sizes (n): VEH (7), THC (9). (D) Representative western blot for pmTOR and t-mTOR expression in the vHipp (top). No significant changes in p-mTOR, t-mTOR and the ratio of phosphorylated to total mTOR
were found between groups. Group sizes (n): VEH (6), THC (6). Respective treatment groups were compared using unpaired Student’s t
test. * indicated p < 0.05. Error bars represent the standard error of the means (SEMs).
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Figure 4. Effects of adolescent THC exposure on the relative abundance and spatial distribution of neurotransmitters GABA and
glutamate. (A) Representative MALDI scans, taken at a bregma of -6.00 mm, showing in situ distribution of neurotransmitters in the dorsal
and ventral hippocampus. (B) MALDI mass spectrometric analysis revealed a significant decrease in the peak area ratios of GABA and no
significant difference in glutamate in the dorsal hippocampus. (C) Similarly, a significant decrease in the peak area ratios of GABA and no
significant difference in glutamate was detected in the ventral hippocampus. Group sizes (n): THC/VEH (8). Respective treatment groups
were compared using one-sample Student’s t test. * indicated p < 0.05; *** p < 0.001. Error bars represent the standard error of the means
(SEMs).
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